搜尋結果
Zealand Pharma Shares Jump 17% After Positive Trial Results For Ozempic Competitor
Forbes· 5 日前Shares for Zealand Pharma rose by over 17% on Friday, after the Danish biotech firm announced positive trial results for ...
The Supreme Court Overruled Roe Two Years Ago, Ending Right To Abortion. Birth Control May Be Next.
Forbes· 5 日前Two years ago in Dobbs v. Jackson the Supreme Court of the United States held that the Constitution of the United States ...
AP Week in Pictures: Latin America and Caribbean
Bastillepost· 5 日前Donald Trump is set to speak Saturday to a group of politically influential evangelicals who ...
Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
CNBC· 6 日前Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a ...
Gilead Shot Prevents 100% of HIV Cases in Trial of African Women
Bloomberg· 6 日前Gilead Sciences Inc.’s experimental twice-yearly shot prevented 100% of HIV cases in women and ...
Bank of England keeps rates at 16-year high before UK election
Reuters· 6 日前The Bank of England kept its main interest rate unchanged at a 16-year high of 5.25% at its ...
Gilead's long-acting HIV drug superior to daily pill Truvada in study
Reuters· 6 日前, opens new tab said on Thursday a late-stage study showed its injectable drug, lenacapavir, ...
Bank of England holds rates steady ahead of UK election
Straits Times· 6 日前The Bank of England (BOE) kept its main interest rate unchanged at a 16-year high of 5.25 per ...
Bank of England keeps rates at 5.25% ahead of UK election
Reuters· 6 日前The Bank of England kept its main interest rate unchanged at a 16-year high of 5.25% on ...
Bank of England to keep rates at 16-year high before UK election
Reuters· 6 日前Britain's central bank looks on course to hold interest rates at a 16-year high of 5.25% on ...